Adamis Pharmaceuticals Corp - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ADMP Nasdaq 2834 http://www.adamispharmaceuticals.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Adamis Pharmaceuticals Corp

Implied Volatility Surging for Adamis Pharmaceuticals (ADMP) Stock Options - Dec 17th, 2018 7:00 am
Novartis to launch Adamis' EpiPen rival in U.S. next year - Dec 6th, 2018 5:19 pm
Adamis Pharmaceuticals Provides Update on the U.S. Launch of SYMJEPI - Dec 6th, 2018 7:30 am
Teva (TEVA) Launches First Generic Version of Mylan's EpiPen - Nov 28th, 2018 6:39 am
Adamis Pharmaceuticals (ADMP) Reports Q3 Loss, Lags Revenue Estimates - Nov 9th, 2018 4:00 pm
Adamis: 3Q Earnings Snapshot - Nov 9th, 2018 2:54 pm
Adamis Pharmaceuticals Announces Third Quarter 2018 Financial Results and Business Update - Nov 9th, 2018 2:46 pm
Adamis Pharmaceuticals (ADMP) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Nov 6th, 2018 8:30 am
Report: Developing Opportunities within Adamis Pharmaceuticals, Cass Information, Celldex Therapeutics, Par Pacific, Inovio Pharmaceuticals, and Liberty Global — Future Expectations, Projections Moving into 2018 - Oct 9th, 2018 5:50 am
Could Adamis Pharmaceuticals Corporation’s (NASDAQ:ADMP) Investor Composition Impacts Your Returns? - Oct 4th, 2018 9:14 am
Adamis Pharmaceuticals Receives FDA Approval for Its Lower Dose Symjepi Product - Sep 27th, 2018 2:05 pm
Adamis Pharmaceuticals (ADMP) in Focus: Stock Moves 8% Higher - Sep 27th, 2018 6:35 am
Adamis Pharmaceuticals, FDA PDUFA Action Anticipated, Analyst Coverage - Sep 26th, 2018 6:15 am
Options Traders Expect Huge Moves in Adamis Pharmaceuticals (ADMP) Stock - Sep 25th, 2018 6:57 am
Mylan’s EpiPen Supply Shortages Continue: What to Expect Ahead - Aug 17th, 2018 8:30 am
Teva Gets FDA Nod for First Generic Version of Mylan's EpiPen - Aug 17th, 2018 7:25 am
Today’s Research Reports on Stocks to Watch: Antares Pharma and Adamis Pharmaceuticals - Aug 17th, 2018 6:00 am
FDA Approves Teva’s Generic Version of EpiPen, Stock Up 7.5% - Aug 16th, 2018 3:02 pm